+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prodrug"

Peptide Drug CDMO Market - Global Forecast 2025-2030 - Product Thumbnail Image

Peptide Drug CDMO Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
From
From
Fully Humanized Antibody Market - Global Forecast 2025-2030 - Product Thumbnail Image

Fully Humanized Antibody Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 180 Pages
  • Global
From
From
From
From
From
From
From
From
Next Generation Drug Conjugates Market 2024 - Product Thumbnail Image

Next Generation Drug Conjugates Market 2024

  • Report
  • December 2024
  • 175 Pages
  • Global
From
From
From
Melflufen Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Melflufen Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
From
Loading Indicator

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases. Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs. The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs. Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more